SHOP APOTHEKE EUROPE TAKES RESPONSIBILTY IN TIMES OF CRISIS.
Venlo, the Netherlands, 24 September 2020. “How companies can combine economic success, sustainability and responsibility” - this was the topic of a two-day online conference hosted by Germany’s renowned FAZ Institute. SHOP APOTHEKE EUROPE CEO Stefan Feltens discussed these subjects along with other high-ranking representatives from politics and business on a live panel and provided insights into the company’s sustainability strategy.
“The ambitious growth targets that we have set ourselves can only be achieved through a sustainable orientation of our company,” emphasised Feltens: “Our stakeholders - whether investors, customers or employees - demand sustainable management; it is therefore a decisive business success factor.”
Even before the start of the Corona crisis, the Management Board of SHOP APOTHEKE EUROPE had identified sustainability as a key strategic issue to be integrated at all levels of the company. “We didn’t just want to dictate something from above but took the time to generate suggestions and ideas for projects with all departments in order to prioritise and successively tackle them together with our employees,” says Feltens.
Climate neutrality is a core issue: Emissions are to be reduced or offset as much as possible in the medium term. SHOP APOTHEKE EUROPE has already successfully launched several initiatives in this area, such as measuring its CO2 footprint in order to define the extent of the necessary reduction and compensation measures. Another important project is the construction of the new company headquarters in Sevenum in Venlo / The Netherlands with solar panels on the roof and no connection to the gas grid. “In the long term, we only want to use renewable energies at all our sites,” Feltens emphasised.
Furthermore, over 60% of all customer orders in Germany are already being shipped using the CO2-neutral DHL Go Green service. Emissions are further reduced through co-operations with local pharmacies in major metropolitan areas like Munich and Berlin.
In addition to a healthy environment, the health of customers and patients is naturally also important for a company like SHOP APOTHEKE EUROPE, explains Feltens: “When we became aware of the dramatic impact of the Corona crisis, we did everything we could to ensure that we could supply our customers with the products relevant to their health as quickly as possible. Our teams adapted processes and capacities to handle the greatly increased order volume and our web shop was accessible at all times”. Employee health has been a priority at all times; a Corona crisis management team was quickly set up to initiate protective measures and prevent a Corona outbreak in the workplace. All employees received a so-called “Corona bonus” for their commitment in dealing with the crisis. This way they share in the economic success achieved through their work - another part of SHOP APOTHEKE EUROPE’s sustainability approach.
ABOUT SHOP APOTHEKE EUROPE.
SHOP APOTHEKE EUROPE is one of the leading and fastest-growing online pharmacies in Continental Europe. With the acquisition of Europa Apotheek Venlo in November 2017, SHOP APOTHEKE EUROPE significantly extended its European market leadership. The product range for the whole family in the areas of OTC, beauty and personal care products as well as prescription drugs is supplemented by high quality natural food and health products, low carb products and sports nutrition following the acquisition of nu3 GmbH in July 2018.
SHOP APOTHEKE EUROPE operates online pharmacies in Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland at this moment. SHOP APOTHEKE EUROPE delivers a broad range of more than 100,000 original products to over 5.5 million active customers (at the end of Q2 2020) fast and at attractive prices. In addition, SHOP APOTHEKE EUROPE provides comprehensive pharmaceutical consulting services.
SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 13 October 2016 and has moved up to the MDAX index on 21 September 2020.
In addition to being traded on the Frankfurt stock exchange, SHOP APOTHEKE EUROPE’S convertible bonds (ISIN: DE000A19Y072) are also tradeable on the Dutch Euronext stock exchange, which operates the stock exchanges in Paris, Amsterdam, Brussels and Lisbon.